Article
Chronic Care,
Health Plans,
2024,
Forum,
Article,
Virtual Care Platform,
Obesity & Weight Care,
Employers
Evolving benefit strategies to promote better cardiometabolic health
The mounting popularity of GLP-1 therapies is changing how people—and the healthcare system—address type 2 diabetes and obesity care. We'll explore the opportunities and risks of these therapies and examine the role of these medications in the long-term management of two of the costliest conditions organizations face.